Advanced search
Publication Cover
mAbs Volume 16, 2024 - Issue 1
Submit an article Journal homepage
773
Views
0
CrossRef citations to date
0
Altmetric
Report

Alternative splicing for tuneable expression of protein subunits at desired ratios

Christel Aebischer-Gumya Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Pierre Morettia Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Timothee Brunstein Laplacea Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Jana Franka Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Ysaline Granda Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Farid Mosbaouia Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Emilie Hilya Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Anna Galeaa Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Megane Peltreta Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Carole Estoppeyb Antibody Engineering, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
,
Daniel Ayoubc Analytical Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandORCID Iconhttps://orcid.org/0000-0001-6433-9917View further author information
ORCID Icon,
Roberto Giovanninid Process Sciences, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
&
Martin Bertschingera Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandCorrespondence[email protected]
View further author information
 show all
Article: 2342243 | Received 16 Jun 2023, Accepted 09 Apr 2024, Published online: 22 Apr 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.